Capecitabine/cisplatin/trastuzumabGastric cancer perforation and peritonitis: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2017年 / 1637卷 / 1期

关键词：

D O I：

10.1007/s40278-017-25930-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：48 / 48

相关论文

共 50 条

[21] BevacizumabGastrointestinal perforation: 2 case reports
Reactions Weekly, 2023, 1942 (1) : 74 - 74
[22] AntineoplasticsBowel perforation: 2 case reports
Reactions Weekly, 2015, 1557 (1) : 35 - 35
[23] SunitinibBowel perforation: 2 case reports
Reactions Weekly, 2012, 1431 (1) : 35 - 35
[24] MitomycinBladder perforation: 2 case reports
Reactions Weekly, 2015, 1582 (1) : 303 - 303
[25] EtanerceptIntestinal perforation: 2 case reports
Reactions Weekly, 2006, 1103 (1) : 7 - 7
[26] BevacizumabBowel perforation: 2 case reports
Reactions Weekly, 2016, 1600 (1) : 54 - 54
[27] AntitubercularsIntestinal perforation: 2 case reports
Reactions Weekly, 2016, 1610 (1) : 24 - 24
[28] BevacizumabColon perforation: 2 case reports
Reactions Weekly, 2010, 1289 (1) : 12 - 12
[29] SorafenibGastrointestinal perforation: 2 case reports
Reactions Weekly, 2013, 1435 (1) : 23 - 23
[30] BevacizumabColonic perforation: 2 case reports
Reactions Weekly, 2015, 1574 (1) : 48 - 48

← 1 2 3 4 5 →